Dr. Lauren W. Veltri
Claim this profileWest Virginia University Healthcare
Area of expertise
Multiple Myeloma
Lauren W. Veltri has run 2 trials for Multiple Myeloma. Some of their research focus areas include:
Hodgkin's Lymphoma
Lauren W. Veltri has run 1 trial for Hodgkin's Lymphoma.
Affiliated Hospitals
West Virginia University Healthcare
United Hospital Center
Clinical Trials Lauren W. Veltri is currently running
Lenalidomide + Dexamethasone +/- Daratumumab
for Multiple Myeloma
This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells to grow and spread. Giving lenalidomide and dexamethasone with daratumumab may work better in treating patients with smoldering myeloma.
Recruiting
2 awards
Phase 3
12 criteria
OBI-3424
for T-Cell Acute Lymphoblastic Leukemia
This phase I/II trial studies the safety, side effects and best dose of OBI-3424 and how well it works in treating patients with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma that has come back (relapsed) or does not respond to treatment (refractory). Chemotherapy drugs, such as OBI-3424, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. OBI-3424 may reduce the amount of leukemia in the body.
Recruiting
1 award
Phase 1 & 2
19 criteria
More about Lauren W. Veltri
Clinical Trial Related
8 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Lauren W. Veltri has experience with
- Lenalidomide
- Brentuximab Vedotin
- Ipilimumab
- Nivolumab
- Autologous Hematopoietic Stem Cell Transplantation
- Rituximab
Breakdown of trials Lauren W. Veltri has run
Multiple Myeloma
Hodgkin's Lymphoma
Mantle Cell Lymphoma
Acute T-Cell Leukemia
T Lymphoblastic Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lauren W. Veltri specialize in?
Lauren W. Veltri focuses on Multiple Myeloma and Hodgkin's Lymphoma. In particular, much of their work with Multiple Myeloma has involved Stage III patients, or patients who are Stage IV.
Is Lauren W. Veltri currently recruiting for clinical trials?
Yes, Lauren W. Veltri is currently recruiting for 2 clinical trials in Morgantown West Virginia. If you're interested in participating, you should apply.
Are there any treatments that Lauren W. Veltri has studied deeply?
Yes, Lauren W. Veltri has studied treatments such as Lenalidomide, Brentuximab Vedotin, Ipilimumab.
What is the best way to schedule an appointment with Lauren W. Veltri?
Apply for one of the trials that Lauren W. Veltri is conducting.
What is the office address of Lauren W. Veltri?
The office of Lauren W. Veltri is located at: West Virginia University Healthcare, Morgantown, West Virginia 26506 United States. This is the address for their practice at the West Virginia University Healthcare.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.